Brief: Zynerba Pharmaceuticals Reports Q1 Loss Per Share Of $0.20

Zynerba Pharmaceuticals

12/05/2021 11:47

May 12 (Reuters) - Zynerba Pharmaceuticals Inc  ZYNE.O :
    * ZYNERBA PHARMACEUTICALS REPORTS FIRST QUARTER 2021
FINANCIAL
RESULTS AND OPERATIONAL HIGHLIGHTS
    * Q1 LOSS PER SHARE $0.20
    * Q1 EARNINGS PER SHARE ESTIMATE $-0.25 -- REFINITIV IBES
DATA
    * RECONNECT, A CONFIRMATORY PIVOTAL TRIAL OF ZYGEL IN
PATIENTS
WITH FXS, EXPECTED TO BE INITIATED IN Q3 OF 2021
    * CASH RUNWAY WELL INTO FIRST HALF 2024; $93.1 MILLION AT
MARCH
31, 2021

Source text for Eikon:  ID:nGNX1pxXf0 
Further company coverage:  ZYNE.O 

 ((Reuters.Briefs@thomsonreuters.com;))